These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 8786328
1. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating M. J Immunol; 1996 Apr 01; 156(7):2624-30. PubMed ID: 8786328 [Abstract] [Full Text] [Related]
2. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW. Oncogene; 1996 Mar 07; 12(5):1055-62. PubMed ID: 8649796 [Abstract] [Full Text] [Related]
3. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B, Daniel PT. Leukemia; 2002 Jun 07; 16(6):1035-44. PubMed ID: 12040435 [Abstract] [Full Text] [Related]
4. Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells. Kobylinska A, Blonski JZ, Hanausek M, Walaszek Z, Robak T, Kilianska ZM. Oncol Rep; 2004 Mar 07; 11(3):699-705. PubMed ID: 14767525 [Abstract] [Full Text] [Related]
5. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. Bannerji R, Kitada S, Flinn IW, Pearson M, Young D, Reed JC, Byrd JC. J Clin Oncol; 2003 Apr 15; 21(8):1466-71. PubMed ID: 12697868 [Abstract] [Full Text] [Related]
6. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K, Sheridan DP. Am J Hematol; 2004 Jan 15; 75(1):22-33. PubMed ID: 14695629 [Abstract] [Full Text] [Related]
7. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells. Santini V, Gozzini A, Scappini B, Caporale R, Zoccolante A, Rigacci L, Gelardi E, Grossi A, Alterini R, Ferrini PR. Haematologica; 1999 Oct 15; 84(10):897-904. PubMed ID: 10509037 [Abstract] [Full Text] [Related]
8. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs. Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A, Brugiatelli M. Haematologica; 1997 Oct 15; 82(1):16-20. PubMed ID: 9107076 [Abstract] [Full Text] [Related]
10. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Dewson G, Snowden RT, Almond JB, Dyer MJ, Cohen GM. Oncogene; 2003 May 01; 22(17):2643-54. PubMed ID: 12730678 [Abstract] [Full Text] [Related]
11. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C, Cosialls AM, Barragán M, Iglesias-Serret D, Santidrián AF, Coll-Mulet L, de Frias M, Domingo A, Pons G, Gil J. Exp Hematol; 2006 Dec 01; 34(12):1663-9. PubMed ID: 17157163 [Abstract] [Full Text] [Related]
12. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report. Ahmad I, Al-Katib AM, Beck FW, Mohammad RM. Clin Cancer Res; 2000 Apr 01; 6(4):1328-32. PubMed ID: 10778958 [Abstract] [Full Text] [Related]
13. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. Schwänen C, Hecker T, Hübinger G, Wölfle M, Rittgen W, Bergmann L, Karakas T. Leukemia; 2002 Oct 01; 16(10):2096-105. PubMed ID: 12357363 [Abstract] [Full Text] [Related]
14. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients. Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M. Lab Hematol; 2006 Oct 01; 12(4):187-92. PubMed ID: 17118768 [Abstract] [Full Text] [Related]
15. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Sanz L, Garcia-Marco JA, Casanova B, de La Fuente MT, García-Gila M, Garcia-Pardo A, Silva A. Biochem Biophys Res Commun; 2004 Mar 12; 315(3):562-7. PubMed ID: 14975737 [Abstract] [Full Text] [Related]
16. Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. Mengubas K, Riordan FA, Bravery CA, Lewin J, Owens DL, Mehta AB, Hoffbrand AV, Wickremasinghe RG. Oncogene; 1999 Apr 15; 18(15):2499-506. PubMed ID: 10229201 [Abstract] [Full Text] [Related]
17. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. McElligott AM, Maginn EN, Greene LM, McGuckin S, Hayat A, Browne PV, Butini S, Campiani G, Catherwood MA, Vandenberghe E, Williams DC, Zisterer DM, Lawler M. Cancer Res; 2009 Nov 01; 69(21):8366-75. PubMed ID: 19826055 [Abstract] [Full Text] [Related]
18. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Pahler JC, Ruiz S, Niemer I, Calvert LR, Andreeff M, Keating M, Faderl S, McConkey DJ. Clin Cancer Res; 2003 Oct 01; 9(12):4570-7. PubMed ID: 14555532 [Abstract] [Full Text] [Related]
19. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. Moon EY, Lerner A. Cancer Res; 2002 Oct 15; 62(20):5711-9. PubMed ID: 12384529 [Abstract] [Full Text] [Related]
20. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells. Ahmed N, Laverick L, Sammons J, Zhang H, Maslin DJ, Hassan HT. Anticancer Res; 2001 Oct 15; 21(5):3519-23. PubMed ID: 11848518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]